{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:15:55Z","timestamp":1791490555388,"version":"4.3.4"},"reference-count":119,"publisher":"Korean Association of Internal Medicine","issue":"5","license":[{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1C1C1006818"],"award-info":[{"award-number":["2022R1C1C1006818"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kjim.org"],"crossmark-restriction":true},"short-container-title":["Korean J Intern Med"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:p>Cancer treatment-induced bone loss (CTBL) is associated with anti-tumor treatments, including endocrine therapies, chemotherapeutic treatments, radiotherapy, glucocorticoids, and tyrosine kinase inhibitors. Osteoporosis, characterized by the loss of bone mass, can increase the risk of fractures, leading to mortality and long-term disability, even after cancer remission. Cancer and osteoporosis have marked clinical and pathogenetic similarities. Both have a multifactorial etiology, affect the geriatric population, and markedly influence quality of life. Lifestyle management, including calcium and vitamin D supplementation, is recommended but the supporting evidence is limited. Oral and injectable bisphosphonates are effective for osteoporosis and malignant bone disease. Bisphosphonates increase bone mineral density (BMD) in patients with CTBL. Denosumab is also used in the management of CTBL; in clinical trials, it improved BMD and reduced the risk of fracture. Currently, there are no bone anabolic therapies for patients with cancer. Appropriate therapies are necessary to maintain optimal bone health, particularly in patients at heightened risk.<\/jats:p>","DOI":"10.3904\/kjim.2023.386","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:14:21Z","timestamp":1709597661000},"page":"731-745","update-policy":"https:\/\/doi.org\/10.3904\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cancer treatment-induced bone loss"],"prefix":"10.3904","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3960-8470","authenticated-orcid":true,"given":"Yong Jun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2270","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.09.003"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(18)30047-0"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2017.03.001"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0173-y"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2744"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.01.035"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1703481"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2022.100459"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0172-4"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3747\/co.2008.174"},{"key":"ref11","first-page":"1353","volume-title":"Physiology and pathophysiology of bone remodeling","author":"Raisz","year":"1999"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.09.047"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra030831"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000486060"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ncpuro0995"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4933-2-14"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/nejmcp1800214"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-023-01414-1"},{"key":"ref19","first-page":"594","volume-title":"NCCN Guidelines \u00ae Insights: breast cancer, version 4.2023","author":"Gradishar","year":"2023"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30165-3"},{"key":"ref21","first-page":"1571","volume-title":"Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study","author":"Harbeck","year":"2021"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/jco.1996.14.1.78"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2019.100254"},{"key":"ref24","first-page":"509","volume-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","author":"Dowsett","year":"2010"},{"key":"ref25","first-page":"107","volume-title":"Adjuvant exemestane with ovarian suppression in premenopausal breast cancer","author":"Pagani","year":"2014"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2008.07.013"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.11.0726"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0810818"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(07)70003-7"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr242"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e403"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(10)70257-6"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx141"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.08.148"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2955-3"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(08)70204-3"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj128"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052477"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1530\/erc-21-0098"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2147\/cia.s115472"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(00)00895-5"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa041943"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4722-3"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.00.6908"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2014.31"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3724"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12167"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1566"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1715546"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1815671"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1800536"},{"key":"ref52","first-page":"47","volume-title":"Magnesium metabolism and its disorders","author":"Swaminathan","year":"2003"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0416"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(15)70064-1"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-009-0083-4"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2000.18.7.1570"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078043"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100363"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22807"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2012.03.027"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.23034"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2012.03.037"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100385"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1080\/02841860701218642"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/108451"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.11.1"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt560"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3186"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/nature03095"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.084145"},{"key":"ref71","first-page":"239s","volume-title":"David A. Karnofsky Award lecture. Imatinib as a paradigm of targeted therapies","author":"Druker","year":"2003"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1038\/nrd839"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds198"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2135-8"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-237404"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-104281"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-010-9429-1"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa051140"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.02.005"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1530\/erc-12-0400"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt026"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2004.07.013"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0417-8"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33592"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2014.06.030"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.20.2587"},{"key":"ref87","first-page":"652","volume-title":"Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer. A cohort study based on 8,507 patients","author":"Dybvik","year":"2014"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2011.07.046"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1396"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.4158\/gl-2020-0524suppl"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-013-0166-8"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3726"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0051"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.11.002"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-017-4237-3"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2013.08.001"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.24.5902"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26313"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds277"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2011.08.002"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0806285"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2021.100409"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-07-5101"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.3816\/cbc.2009.n.015"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.02.004"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0261"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3816\/cgc.2007.n.003"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-6-200703200-00006"},{"key":"ref109","first-page":"e129","volume-title":"Clinical fracture incidence in metastatic hormone-sensitive prostate cancer (mHSPC) and risk-reduction following addition of zoledronic acid to androgen deprivation therapy (ADT) with or without docetaxel (DOC): long-term results from 2 phase 3 trials fro","author":"Jones","year":"2023"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2008.16.3832"},{"key":"ref111","first-page":"433","volume-title":"Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial","author":"Gnant","year":"2015"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0809003"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2017.1362389"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2008.03.007"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0215"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2021.100355"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1200\/jco.19.01696"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01087-0"},{"key":"ref119","volume-title":"","year":"c2021"}],"container-title":["The Korean Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.kjim.org\/upload\/kjim-2023-386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.kjim.org\/journal\/view.php?doi=10.3904\/kjim.2023.386","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.kjim.org\/upload\/kjim-2023-386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T02:43:20Z","timestamp":1725590600000},"score":1,"resource":{"primary":{"URL":"http:\/\/kjim.org\/journal\/view.php?doi=10.3904\/kjim.2023.386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"URL":"https:\/\/doi.org\/10.3904\/kjim.2023.386","relation":{},"ISSN":["1226-3303","2005-6648"],"issn-type":[{"value":"1226-3303","type":"print"},{"value":"2005-6648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]},"assertion":[{"value":"2023-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-05","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}